Analysis of morphological vascular changes of hepatocellular carcinoma by microflow imaging using contrast-enhanced sonography

Hepatology Research

Volumn 38, Issue 8, 2008, Pages 790-799

  Sugimoto, Katsutoshi ^a   Moriyasu, Fuminori ^a   Kamiyama, Naohisa ^b   Metoki, Ryo ^a   Yamada, Masahiko ^a   Imai, Yasuharu ^a   Iijima, Hiroko ^c  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b TOSHIBA MEDICAL SYSTEMS CORPORATION   (Japan)

^c HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Contrast agent; Hepatocellular carcinoma; Histological differentiation; Microflow imaging; Ultrasonography

Indexed keywords

SONOVUE;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; GRAY SCALE ECHOGRAPHY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER BLOOD FLOW; LIVER BLOOD VESSEL; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MICROCIRCULATION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TUMOR BLOOD FLOW; TUMOR DIFFERENTIATION; TUMOR VASCULARIZATION;

EID: 47649127946     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2008.00331.x     Document Type: Article

References (39)

1. Di Bisceglie AM. Hepatitis C and hepatocellular carcinoma. Hepatology 1997; 26: 34S-38S.
2. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999; 340: 745-50.
3. Colombo M. Hepatocellular carcinoma. J Hepatol 1992; 15: 225-36.
4. Collier J, Sherman M. Screening for hepatocellular carcinoma. Hepatology 1998; 27: 273-8.
5. Trinchet JC, Beaugrand M. Treatment of hepatocellular carcinoma in patients with cirrhosis. J Hepatol 1997; 27: 756-65.
6. Bruix J. Treatment of hepatocellular carcinoma. Hepatology 1997; 25: 259-62.
7. Mor E, Kaspa RT, Sheiner P, Schwartz M. Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation. Ann Intern Med 1998; 129: 643-53.
8. Bruix J, Sherman M, Llovet JM et al. Clinical management of hepatocellular carcinoma: Conclusions of the Barcelona 2000 EASL Conference. J Hepatol 2001; 35: 421-30.
9. Takayasu K, Moriyama N, Muramatsu Y et al. The diagnosis of small hepatocellular carcinomas: Efficacy of various imaging procedures in 100 paients. AJR 1990; 155: 49-54.
10. Szklaruk J, Silverman PM, Charnsangavej C. Imaging in the diagnosis, staging, treatment, and surveillance of hepatocellular carcinoma. AJR 2003; 180: 441-54.
11. Lee HM, Lu DS, Krasny RM, Busuttil R, Kadell B, Lucas J. Hepatic lesion characterization in cirrhosis: Significance of arterial hypervascularity on dual-phase herical CT. AJR 1997; 169: 125-30.
12. Teefey A, Hildeboldt CC, Dehdashti F et al. Detection of primary hepatic malignancy in liver transplant candidates: Prospective comparison of CT, MR imaging, US, and PET. Radiology 2003; 226: 533-42.
13. Baron RL, Oliver JH III, Dodd GD III, Nalesnik M, Holbert BL, Carr B. Hepatocellular carcinoma: Evaluation with biphasic, contrast-enhanced, helival CT. Radiology 1996; 199: 505-11.
14. Miller WJ, Baron RL, Dodd GD 3rd, Federle MP. Malignancies in patients with cirrhosis: CT sensitivity and specificity in 200 consecutive transplant patients. Radiology 1994; 193: 645-50.
15. Brancatelli G, Baron RL, Pererson MS, Marsh W. Helical CT screening for hepatocellular carcinoma in patients with cirrhosis: Frequency and causes of false-positive interpretation. AJR 2003; 180: 1007-14.
16. Kojiro M. Histopathology of liver cancers. Best Pract Res Clin Gastroenterol 2005; 19: 39-62.
17. Sun B, Zhang S, Zhang D et al. Vasculogenic mimicry is associated with high tumor grade, invasion and metastasis, and short survival in patients with hepatocellular carcinoma. Oncol Rep 2006; 16: 693-8.
18. Kanematsu M, Hoshi H, Takao H, Sugiyama Y. Abdominal wall tumor seeding at sonographically guided needle-core aspiration biopsy of hepatocellular carcinoma. AJR 1997; 169: 1198-9.
19. Takamori R, Wong LL, Dang C, Wong L. Needletract implantation from hepatocellular cancer: Is needle biopsy of the liver always necessary? Liver Transpl 2000; 6: 67-72.
20. Torzilli G, Minagawa M, Takayama T et al. Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy. Hepatology 1999; 30: 889-93.
21. Kim SH, Lim HK, Lee WJ, Cho JM, Jang HJ. Needle-tract implantation in hepatocellular carcinoma: Frequency and CT findings after biopsy with a 19.5-gauge automated biopsy gun. Abdom Imaging 2000; 25: 246-50.
22. Yu HC, Cheng JS, Lai KH et al. Factors for early tumor recurrence of single small hepatocellular carcinoma after percutaneous radiofrequency ablation therapy. World J Gastroenterol 2005; 11: 1439-44.
23. Numata K, Tanaka K, Kiba T et al. Contrast-enhanced, wide-band harmonic gray scale imaging of hepatocellular carcinoma. J Ultrasound Med 2001; 20: 89-98.
24. Wilson SR, Burns PN, Murdali D et al. Harmonic hepatic US with microbubbles contrast agents: Initial experience showing improved characterization of hemangioma, hepatocellular carcinoma and metastasis. Radiology 2000; 215: 147-51.
25. Choi BI, Kim TK, Han JK, Kim AY, Chang KS, Park JP. Vascularity of hepatocellular carcinoma: Assessment with contrast-enhanced second harmonic versus conventional power Doppler US. Radiology 2000; 214: 381-6.
26. Kim TK, Choi BI, Han JK, Hong HS, Park SH, Moon SG. Hepatic tumor: contrast agent-enhancement patterns with pulse-inversion harmonic US. Radiology 2001; 216: 411-17.
27. Tanaka S, Ioka T, Oshikawa O, Hamada Y, Yoshioka F. Dynamic sonography of hepatic tumors. AJR 2001; 177: 799-805.
28. Sirlin CB, Girard MS, Baker KG, Steinbach GC, Deiranieh LH, Mattrey RF. Effect of acquisition rate on liver and portal vein enhancement with microbubble contrast. Ultrasound Med Biol 1999; 25: 331-8.
29. Wei K, Jayaweera AR, Firoozan S et al. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administrated as a contrast venous infusion. Circulation 1998; 97: 473-83.
30. Metoki R, Moriyasu F, Kamiyama N et al. Quantification of hepatic parenchymal blood flow by contrast ultrasonography with flash-replenishment imaging. Ultrasound Med Biol 2006; 32: 1459-66.
31. International Working Party. Terminology of nodular hepatocellular lesions. Hepatology 1995; 22: 983-93.
32. Burns PN, Wilson SR. Focal liver masses: Enhancement patterns on concordance of US scans with CT scans and MR images. Radiology 2007; 242: 162-74.
33. Hotta N, Tagava T, Maeno T et al. Advanced dynamic flow imaging with contrast-enhanced ultrasonography for the evaluation of tumor vascularity in liver tumors. Clin Imaging 2005; 29: 34-41.
34. Solbiati L, Tonillini M, Cova L, Goldberg N. The role of contrast-enhanced ultrasound in the detection of focal liver lesions. Eur Radiol 2001; 11: E15-26.
35. Nicolau C, Catala V, Vilana R et al. Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: correlation with cellular differentiation. Eur Radiol 2004; 14: 1092-9.
36. Zhi-Hui Fan, Min-HuaChen Ying Dai et al. Evaluation of primary malignancies of liver using contrast-enhanced sonography: Correlation with pathology. AJR 2006; 186: 1512-19. 9
37. Ueda K, Terada T, Nakanuma Y et al. Vascular supply in adenomatous hyperplasia of the liver and hepatocellular carcinoma: A morphologic study. Hum Pathol 1992; 23: 619-26.
38. Kojiro M, Nakashima O. Histopathologic evaluation of hepatocellular carcinoma with a special reference to small early stage tumor. Semin Liver Dis 1999; 19: 287-96.
39. Liver Cancer Study Group of Japan. General Rules for the Clinical and Pathological Study of Primary Liver Cancer, 2nd edn. Tokyo: Kanehara, 2003.